Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome: The dissociation of HDL-C and triglycerides

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages E1676-E1680

  Joseph, Jalaja ^a   Shamburek, Robert D ^b   Cochran, Elaine K ^a   Gorden, Phillip ^a   Brown, Rebecca J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METRELEPTIN; TRIACYLGLYCEROL; LEPTIN;

ADOLESCENT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; DRUG EFFECT; FEMALE; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY ASSOCIATED METABOLIC SYNDROME; OPEN STUDY; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; CHILD; CLINICAL TRIAL; DRUG EFFECTS; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; LIPODYSTROPHY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; TRIGLYCERIDES; YOUNG ADULT;

EID: 84907204981     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1878     Document Type: Article

References (20)

1. Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes. 2005;54: 1994-2002.
2. Garg A. Lipodystrophies: Genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96: 3313-3325.
3. Chong AY, Lupsa BC, Cochran EK, Gorden P. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia. 2010;53: 27-35.
4. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association, National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109: 433-438.
5. Gorden P, Lupsa BC, Chong AY, Lungu AO. Is there a human model for the 'metabolic syndrome' with a defined aetiology? Diabetologia. 2010;53: 1534-1536.
6. Chan DC, Watts GF, Barrett PH,MamoJC, Redgrave TG. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clin Chem. 2002;48: 278-283.
7. Miller M, Langenberg P, Havas S. Impact of lowering triglycerides on raising HDL-C in hypertriglyceridemic and non-hypertriglyceridemic subjects. Int J Cardiol. 2007;119: 192-195.
8. ACCORD Study Group; Ginsberg HN, Elam MB, Lovato LC, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362: 1563-1574.
9. Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: Four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170: 1566-1575.
10. Sjöström L, Lindroos AK, Peltonen M; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351: 2683-2693.
11. Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, onHDLremodeling in obese women. J Lipid Res. 2010;51: 2405-2412.
12. Horton JD, Goldstein JL, Brown MS. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109: 1125-1131.
13. Shimomura I, Bashmakov Y, Horton JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem. 1999;274: 30028-30032.
14. Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia. 1976;12: 563-571.
15. Duez H, Lamarche B, Uffelman KD, Valero R, Cohn JS, Lewis GF. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006;26: 1357-1363.
16. Tan CE, Foster L, Caslake MJ, et al. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscler Thromb Vasc Biol. 1995;15: 1839-1848.
17. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96: 1221-1232.
18. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 1991;88: 2059-2066.
19. Hegele RA. Premature atherosclerosis associated with monogenic insulin resistance. Circulation. 2001;103: 2225-2229.
20. Weterings AA, van Rijsingen IA, Plomp AS, et al. A novel lamin A/C mutation in a Dutch family with premature atherosclerosis. Atherosclerosis. 2013;229: 169-173.